Written Exposure Therapy for Nurses

Last updated: May 28, 2024
Sponsor: University of Texas at Austin
Overall Status: Completed

Phase

1

Condition

Post-traumatic Stress Disorders

Depression

Treatment

WET

Clinical Study ID

NCT06432374
HUM00203166
  • Ages > 18
  • All Genders

Study Summary

Nurses often experience elevated levels of stress, overwork, and trauma in the workplace, leading to posttraumatic stress disorder (PTSD), depression, burnout, and even nurse turnover. While effective therapies for PTSD exist, barriers to treatment arise from nursing culture, such as workplace stigma about mental health problems, fear that psychological status may impact performance evaluations, and demands of shiftwork. There is a pressing need for scalable evidence-based interventions tailored to nursing culture to effectively address PTSD and related mental health issues. The study aimed to assess the feasibility, safety, and acceptability of a tailored evidence-based treatment, Written Exposure Therapy (WET), for nurses experiencing work-related traumatic stress.

This single-arm open pilot study with pre- and post-intervention assessments, included participants from two nursing schools' alumni. Eligibility criteria included nurses screening positive for work-related trauma with a report of at least two PTSD symptoms. Participants engaged in a self-administered, asynchronous, five-week online writing session, facilitated by WET-trained nurses. Outcomes measures (PTSD, depression, anxiety, burnout, and intention to quit) were assessed at baseline, post-intervention, and 5-weeks follow-up.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Work-related trauma

  • Posttraumatic stress disorder

Exclusion

Exclusion Criteria:

  • Current substance abuse

  • Current suicidality

  • Current psychiatric treatment with psychotherapy or psychotropic medications otherthan selective serotonin (and norepinephrine) reuptake inhibitors (SSRI/SNRI).

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: WET
Phase: 1
Study Start date:
February 01, 2022
Estimated Completion Date:
September 01, 2023

Connect with a study center

  • University of Michigan

    Ann Arbor, Michigan 48104
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.